Bivirkninger observeret i fase II/ III kliniske afprøvninger er opført nedenfor efter organklasse (meget almindelig > 1/ 10, almindelig < 1/ 10 and > 1/ 100):
On the basis of the available data there is no evidence that sibutramine is associated with electrolyte imbalance and serotonin syndrome.